Biologics Distributor for Orthopedic Practices in Huntsville, AL

Receiving cold-chain shipments in the Southeast

Cryopreserved Wharton's jelly and exosome formats are stored at -80 degrees C before shipping and travel overnight on dry ice in validated containers. Summer heat and humidity in the Southeast make prompt receiving especially important: practices should plan for someone to accept and transfer cryopreserved shipments to proper storage as soon as they arrive rather than leaving them at a front desk.

Lyophilized formats avoid that concern entirely, since they are shelf-stable and do not require cryogenic handling once received.

What Huntsville practices typically ask before approving a new supplier

Orthopedic groups bringing on a new tissue or biologics vendor generally request a certificate of analysis for the lot in question, a donor eligibility summary, and a description of the recovery and processing timeline, then compare that against their own purchasing and compliance checklist.

• Certificate of analysis (COA) by lot
• Donor eligibility and serology screening summary
• Sterility testing and lot release record
• Shipping container validation documentation

Licensure and regulatory review

Precision Biologics does not determine whether a particular intended use fits within the HCT/P framework for Wharton's jelly products, or the regulatory posture that applies to exosome articles; that determination belongs to your practice and its own counsel.

Huntsville-based practices should confirm their licensure and scope-of-practice requirements with the Alabama Board of Medical Examiners before finalizing a purchasing decision. These products are not FDA approved or licensed for any disease or condition; this page is written for licensed healthcare professionals and is not medical or legal advice.

Opening an account

A valid NPI number is required to open an account, and verification happens before the first order ships. Once approved, your practice can request lot documentation on demand and schedule a peer-to-peer call between your physician and a Precision Biologics contact focused on reviewing that documentation.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.